If you’re on testosterone injections, expect blood work at 3 to 6 months after starting, again at 12 months, and then once a year after that as long as your levels are stable. That schedule covers the critical early adjustment period and then shifts to routine maintenance monitoring. The exact timing of your blood draw relative to your injection matters too, because drawing at the wrong point in your cycle can give misleading results.
The Standard Monitoring Schedule
The Endocrine Society’s clinical guidelines lay out a clear timeline. During your first year on testosterone injections, you need labs drawn at two key checkpoints: once between 3 and 6 months after starting, and again at 12 months. These early tests confirm that your dose is actually putting you in the right range and that your body is handling the therapy without problems.
After that first year, if your results are stable and your dose hasn’t changed, annual blood work is the standard recommendation. “Stable” means your testosterone is consistently landing in the target range, your red blood cell count isn’t creeping up, and you aren’t experiencing new symptoms. Any dose adjustment resets the clock. If your doctor changes your dose or injection frequency, you’ll typically need follow-up labs 3 to 6 months later to verify the new regimen is working.
When to Get Your Blood Drawn
The day you get your blood drawn relative to your last injection has a significant impact on your results. Testosterone levels from injections aren’t constant. They spike after the injection and gradually decline until your next one. To get a useful reading, you need to time the draw correctly for your specific formulation.
For testosterone cypionate and testosterone enanthate (the two most common injectable forms), blood should be drawn about one week after your last injection. This captures your trough level, the lowest point in your cycle, which is what your doctor uses to make dosing decisions. If you’re on testosterone undecanoate (a longer-acting injection given less frequently), the draw should happen just before your next scheduled injection.
The target most clinicians aim for is a trough level between 400 and 700 ng/dL, though some sources use a slightly broader range of 350 to 750 ng/dL. If your trough is below 400, your dose may need to go up. If it’s above 700 at the lowest point in your cycle, you’re likely spending much of the time well above the normal range, which increases the risk of side effects.
What Gets Tested Beyond Testosterone
Your testosterone level is only one piece of the picture. Several other markers get checked on the same schedule, each for a specific reason.
- Hematocrit (red blood cell concentration): Testosterone stimulates your bone marrow to produce more red blood cells. That’s fine up to a point, but if your blood gets too thick, it raises the risk of clots, stroke, and other cardiovascular problems. Hematocrit is checked at baseline, again at 3 to 6 months, and then annually. If it rises above 54%, guidelines call for stopping therapy until it drops back to a safe level. Some clinicians use a more conservative cutoff of 52%.
- PSA (prostate-specific antigen): For men 55 to 69, or men 40 and older with elevated prostate cancer risk, PSA and a digital rectal exam are recommended at baseline and again within the first year. After that, prostate monitoring follows standard age-based cancer screening guidelines.
- Estradiol: Testosterone converts to estrogen in your body through a natural process. Most guidelines don’t call for routine estradiol testing unless you develop specific symptoms like breast tenderness, breast tissue growth, unexplained fluid retention, mood changes, or a drop in libido that doesn’t match your testosterone levels. If those symptoms show up, your doctor will check estradiol to see if elevated estrogen is the cause.
Why the First Year Matters Most
The monitoring schedule is front-loaded for good reason. Most side effects and dosing problems surface in the first 6 to 12 months. Your body is adjusting to a new hormonal baseline, and the dose your doctor started you on is an educated guess based on your labs and symptoms. It almost always needs fine-tuning.
Hematocrit tends to rise most sharply in the early months of therapy and then plateau. Catching a rapid increase early gives your doctor the chance to lower your dose or adjust your injection frequency before levels hit a dangerous threshold. The 54% cutoff for stopping therapy isn’t arbitrary. Above that level, your blood becomes viscous enough to meaningfully increase cardiovascular risk. If you started with a baseline hematocrit near 50%, guidelines actually recommend against beginning testosterone therapy until that’s addressed, often by screening for sleep apnea or other underlying causes.
Symptom improvement also follows a timeline that informs monitoring decisions. Energy and mood changes often appear within weeks, but effects on body composition, bone density, and sexual function can take 3 to 6 months to fully develop. The first blood draw at 3 to 6 months coincides with this window, giving your doctor both lab data and your symptom report to evaluate together.
What Changes During Long-Term Monitoring
Once you’ve been on a stable dose for a year or more with consistent lab results, the monitoring burden drops considerably. Annual blood work covering testosterone and hematocrit becomes the baseline expectation. Your doctor will also ask about symptoms at each visit, because lab numbers alone don’t tell the whole story. A testosterone level of 500 ng/dL might feel great for one person and inadequate for another.
Some clinics check labs every 3 to 4 months indefinitely, particularly if they’re also tracking estradiol or other markers. This is more aggressive than what major guidelines recommend for stable patients, but it’s common in practices that specialize in hormone optimization. If your doctor orders more frequent testing, it’s not necessarily a sign that something is wrong. It may just reflect their clinical approach.
The practical takeaway: don’t skip your annual labs even if you feel fine. Hematocrit can creep up slowly over years without symptoms, and catching it at 52% gives you options that aren’t available at 56%. The whole point of monitoring is to stay ahead of problems rather than react to them.
Signs You May Need Testing Sooner
Outside the scheduled intervals, certain symptoms warrant getting labs drawn earlier. A return of the fatigue, low mood, or sexual dysfunction that brought you to testosterone therapy in the first place could mean your levels have drifted below the therapeutic range. This sometimes happens if your pharmacy switches manufacturers or if your injection technique changes (injecting into a different muscle or depth can affect absorption).
On the other side, symptoms of excess testosterone or elevated estrogen, such as increased acne, breast tenderness, water retention, mood swings, or unusually high energy followed by crashes, suggest your levels may be running too high at peak or that more testosterone is converting to estrogen than expected. Headaches, dizziness, or skin that looks unusually flushed can point to rising hematocrit. Any of these are worth a call to your doctor and an unscheduled blood draw rather than waiting for your next routine check.